Journal
CHEMISTRY & BIOLOGY
Volume 17, Issue 12, Pages 1344-1355Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2010.10.009
Keywords
-
Categories
Funding
- National Institutes of Health (NIGMS) [77253]
- Alnylam Pharmaceuticals
- Robert A. Welch Foundation [I-1244]
Ask authors/readers for more resources
Low-density lipoprotein receptor (LDLR) is a cell-surface receptor that plays a central role in regulating cholesterol levels. Increased levels of LDLR would lead to reduced cholesterol levels and contribute to strategies designed to treat hypercholesterolemia. We have previously shown that duplex RNAs complementary to transcription start sites can associate with noncoding transcripts and activate gene expression. Here we show that duplex RNAs complementary to the promoter of LDLR activate expression of LDLR and increase the display of LDLR on the surface of liver cells. Activation requires complementarity to the LDLR promoter and can be achieved by chemically modified duplex RNAs. Promoter-targeted duplex RNAs can overcome repression of LDLR expression by 25-hydroxycholesterol and do not interfere with activation of LDLR expression by lovastatin. These data demonstrate that small RNAs can activate LDLR expression and affect LDLR function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available